Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Thomason

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Journal of Neurovirology|September 2, 2015
Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trialAlejandro Arenas-Pinto, Jennifer Thompson, Godfrey Musoro, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2013
Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trialQuirine Fillekes, Eva P Muro, Catherine Chunda, et al.
AIDS (London, England)|June 29, 2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tabletsQuirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
Infectious Diseases in Obstetrics and Gynecology|January 1, 1996
Comparative study of intravaginal metronidazole and triple-sulfa therapy for bacterial vaginosisJ D Sobel, W Chaim, J Thomason, et al.
AIDS (London, England)|March 5, 2008
Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tabletsRafaëlla F A L'homme, Desiré Kabamba, Fiona M Ewings, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2002
Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetesH M Colhoun, M J Thomason, M I Mackness, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetesM J Thomason, H M Colhoun, S J Livingstone, et al.
Annals of Clinical Microbiology and Antimicrobials|April 25, 2021
The niche of One Health approaches in Lassa fever surveillance and controlLiã Bárbara Arruda, Najmul Haider, Ayodeji Olayemi, et al.
Lancet (London, England)|August 25, 2004
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialHelen M Colhoun, D John Betteridge, Paul N Durrington, et al.
Atherosclerosis|June 24, 2003
The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart diseaseS S Soedamah-Muthu, H M Colhoun, M J Thomason, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Journal of Neurovirology|September 2, 2015
Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trialAlejandro Arenas-Pinto, Jennifer Thompson, Godfrey Musoro, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2013
Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trialQuirine Fillekes, Eva P Muro, Catherine Chunda, et al.
AIDS (London, England)|June 29, 2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tabletsQuirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
Infectious Diseases in Obstetrics and Gynecology|January 1, 1996
Comparative study of intravaginal metronidazole and triple-sulfa therapy for bacterial vaginosisJ D Sobel, W Chaim, J Thomason, et al.
AIDS (London, England)|March 5, 2008
Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tabletsRafaëlla F A L'homme, Desiré Kabamba, Fiona M Ewings, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2002
Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetesH M Colhoun, M J Thomason, M I Mackness, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetesM J Thomason, H M Colhoun, S J Livingstone, et al.
Annals of Clinical Microbiology and Antimicrobials|April 25, 2021
The niche of One Health approaches in Lassa fever surveillance and controlLiã Bárbara Arruda, Najmul Haider, Ayodeji Olayemi, et al.
Lancet (London, England)|August 25, 2004
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialHelen M Colhoun, D John Betteridge, Paul N Durrington, et al.
Atherosclerosis|June 24, 2003
The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart diseaseS S Soedamah-Muthu, H M Colhoun, M J Thomason, et al.
Pageof 16